Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm

J Cell Mol Med. 2013 Oct;17(10):1282-90. doi: 10.1111/jcmm.12103. Epub 2013 Oct 16.

Abstract

Janus kinase-signal transducer and activator of transcription (JAK/STAT) signalling, pivotal in Philadelphia-negative (Ph-ve) myeloproliferative neoplasm (MPN), is negatively regulated by molecules including SOCSs, CISH and SHP1. SOCS1, SOCS2 and SOCS3 methylation have been studied in MPN with discordant results. Herein, we studied the methylation status of SOCS1, SOCS2 and SOCS3, CISH and SHP1 by methylation-specific polymerase chain reaction (MSP) in cell lines and 45 diagnostic marrow samples of Ph-ve MPN. Moreover, we attempted to explain the discordance of methylation frequency by mapping the studied MSP primers to the respective genes. Methylation was detected in normal controls using SOCS2 MSP primers in the 3'translated exonic sequence, but not primers around the transcription start site in the 5' untranslated regions (5'UTR). SOCS1, SOCS2, SOCS3 and CISH were completely unmethylated in primary MPN samples and cell lines. In contrast, methylation of SHP1 was detected in 8.9% primary marrow samples. Moreover, SHP1 was completely methylated in K562 cell line, leading to reversible SHP1 silencing. A review of methylation studies of SOCS1 and SOCS3 showed that spuriously high rates of SOCS methylation had been reported using MSP primers targeting CpG sites in the 3'translated exonic sequence, which is also methylated in normal controls. However, using MSP primers localized to the 5'UTR, methylation of SOCS1, SOCS2 and SOCS3 is infrequent across all studies. In summary, methylation of SOCS1, SOCS2, SOCS3 and CISH is infrequent in Ph-ve MPN. Appropriate MSP primers are important for accurate estimation of the methylation frequency. The role of SHP1 methylation in the pathogenesis of MPN warrants further investigation.

Keywords: CISH; MSP primer; SHP1; SOCS1; SOCS2; SOCS3; methylation; myeloproliferative neoplasms.

MeSH terms

  • Base Sequence
  • Cell Line, Tumor
  • DNA Primers
  • Humans
  • Methylation
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / metabolism*
  • Philadelphia Chromosome*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6 / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Suppressor of Cytokine Signaling Proteins / metabolism*

Substances

  • DNA Primers
  • Suppressor of Cytokine Signaling Proteins
  • cytokine inducible SH2-containing protein
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6